In this episode of The Peter Attia Drive, Dominic D'Agostino explores ketosis and its therapeutic applications. He explains how ketosis can be achieved through different methods—including diet, fasting, and supplements—and discusses its role in treating conditions ranging from drug-resistant seizures to aggressive cancers. D'Agostino details the importance of proper electrolyte management when using ketone supplements and shares specific formulations that help maintain this balance.
The discussion extends to ketogenic therapies' potential in treating neurodegenerative conditions like Alzheimer's disease, where ketones may serve as an alternative fuel source for the brain. D'Agostino and Attia also examine hyperbaric oxygen therapy, particularly its applications in treating traumatic brain injuries and concussions, including specific protocols for treatment and emerging research findings in this area.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
In this episode, Dominic D'Agostino explores the various methods of achieving ketosis and their applications in clinical settings. He explains that ketosis can be reached through fasting, diet (typically 60-90% fat), or supplements, with each method raising blood ketone levels. D'Agostino emphasizes that ketogenic diets have shown particular success in managing drug-resistant seizures in children, with about a third of patients experiencing significant improvement.
D'Agostino discusses the potential of ketogenic diets as a metabolic therapy for cancer, particularly for aggressive cancers like glioblastoma. He highlights ongoing research targeting a specific glucose-ketone index (GKI) of 1-4, combined with various drugs targeting cancer cell metabolism. The approach includes reducing glucose availability and using compounds that inhibit both glycolysis and glutaminolysis in cancer cells.
According to D'Agostino, ketogenic therapies show promise for treating Alzheimer's and other forms of dementia. He explains that glucose hypometabolism is a key characteristic of Alzheimer's, and ketones could serve as an alternative brain fuel source. Currently, 558 registered clinical trials are exploring ketogenic interventions for various neurological conditions, with significant funding being directed toward research in severe psychiatric disorders.
D'Agostino details the importance of managing electrolyte balance when using ketone supplements. He describes new formulations that combine ketone salts with essential electrolytes (sodium, potassium, calcium, and magnesium) to prevent imbalances. These formulations, including products like Keto Start, help mitigate the diet's natriuretic and diuretic effects.
D'Agostino and Peter Attia discuss the promising applications of hyperbaric oxygen therapy (HBOT), particularly for traumatic brain injury and concussion recovery. While not yet FDA-approved for these conditions, emerging research suggests significant improvements in cognitive function, even years after injury. D'Agostino recommends specific protocols, such as two atmospheres of oxygen for 60-90 minutes, five days weekly, for at least 40 sessions in standard cases.
1-Page Summary
On the podcast, Dominic D'Agostino explains the differences and applications between achieving ketosis through diet or supplements, and its implications in clinical settings and personal health.
Ketosis can be attained via fasting, diet, or supplements, leading to elevated blood levels of ketone bodies like beta-hydroxybutyrate or acetylacetate. A typical ketogenic diet is high in fat, with initial protocols recommending 90% fat, while modified versions propose around 60-70%. Notably, D’Agostino emphasizes the importance of protein intake, especially for pediatric epilepsy patients, where insufficient protein can affect growth adversely.
D’Agostino shares that ketogenic diets regulate seizures, particularly in instances where medications fail. Early evidence showed fasting could control seizures, influencing the development of ketogenic diets. A clinical report from 1921 detailed striking effects on epilepsy, given the absence of alternative treatments. Today, about a third of drug-resistant patients can see substantial, even complete, seizure control with ketogenic diets, with a smaller percentage potentially cured following the regimen.
Transitioning to a ketogenic diet may prove challenging initially, hence why electrolytes and ketone salts can help ease this shift. Current supplements in the market can raise ketone levels in the blood similarly to dietary changes, comprising of esters, salts, and precursors, each with their distinct effects on metabolism and [restricted term].
Supplement types vary, with esters known for quick, high ketone spikes, potentially stimulating [restricted term], while salts provide a more sustained rise without such effect. Furthermore, there is potential for select ketone molecules to closely replicate the beneficial redox balance seen in dietary ketosis, targeting a one-to-one ratio of beta-hydroxybutyrate to acetoacetate.
Salts have evolved into products like the packet of Keto Start, providing six to 10 grams of pure beta-hydroxybutyrate without electrolytes. Conversely, salts bound to electrolytes, similar to those in Element, can help mediate the transition effects. Intere ...
Nutritional vs. Supplemental Ketosis
Ketogenic diets are being explored as a potential metabolic therapy for cancer, especially for aggressive cancers like glioblastoma. Research suggests that a specific glucose-ketone index (GKI) and therapies targeting cancer cell metabolism may extend survival.
The episode with Dominic D'Agostino focuses on the prospects for ketogenic diets as metabolic therapy for cancer. D'Agostino highlights the potential applications of 1,3-butanediol, which has a glucose-lowering effect and has been shown to suppress growth in metastatic cancer when mixed with a standard diet, inducing ketosis.
A review called "Ketone Metabolic Therapy Framework for Glioblastoma" with 49 authors, including oncologists and basic science researchers, is being conducted to make metabolic therapy part of the standard care for cancers where standard treatments are less effective. Glioblastoma is the primary focus, but the findings may be applicable to other cancers exhibiting the Warburg effect.
Clinical trials ongoing reveal that achieving and maintaining a GKI of 1-4 is part of a comprehensive, calculated metabolic-based intervention that may include diet, glycolytic drugs, and anti-glutamine drugs, highlighting the benefits of combining these with different drugs to potentially extend survival. The discussions consider ketone metabolic therapy with CAR-T therapy for lymphoma and the possibility that pancreatic cancer may be better suited for demonstrating the effectiveness of ketogenic diets.
A glucose ketone index (GKI) of 1-4, which compares the millimolar concentration of glucose to ketones in the blood, is targeted. Unlike the standard American diet, which results in a GKI of 50, therapy aims for a GKI of between 1 and 4, preparing the body for other treatments. Various drugs targeting glucose metabolism are being considered. One such drug is ...
Ketogenic Diets and Exogenous Ketones For Cancer Therapy
Trials examining ketogenic diets and cancer therapy face obstacles due to various research and logistical challenges.
Dominic D'Agostino notes the slow progress in clinical trials for cancer therapy involving ketogenic diets and exogenous ketones, pointing out the necessity to convince policymakers and funding agencies such as the NIH and the DOD of the potential benefits of ketogenic metabolic therapy. He emphasizes the challenges in trial design, including the necessity of knowledgeable oncologists and dietitians, creating appropriate inclusion-exclusion criteria, and addressing patient heterogeneity.
There's ...
Ketogenic Diets and Exogenous Ketones in Cancer Therapy Trials Face Slow Progress Due to Design and Funding Challenges
The potential for ketogenic diets and ketone supplements to treat neurodegenerative diseases such as Alzheimer's is under investigation. Dominic D'Agostino discusses the role of brain metabolism and systemic inflammation in neurodegenerative conditions and highlights the ongoing research in this area.
D'Agostino reveals that a hallmark characteristic of Alzheimer's disease is glucose hypometabolism. In patients with mild cognitive impairment, which can be interpreted as an early stage of dementia, glucose hypometabolism is a ubiquitous characteristic. He suggests that ketones could provide an alternative fuel source for the brain, which is especially beneficial for patients displaying this condition.
Although not detailed extensively, Dominic D'Agostino shows interest in combining ketosis with other neuroprotective therapies. He talks about the advantages of a comprehensive metabolic-based formula that might incorporate ketones alongside other cofactors and neuroprotective therapies to treat Alzheimer's and other forms of dementia. However, he points out challenges with funding agencies who are reluctant to fund such multi-compound formulas.
D'Agostino touches on the significant research being carried out in the field of ketogenic dietary interventions for neurodegenerative diseases. He mentions 558 registered clinical trials related to ketogenic diets on clinicaltrials.gov. Some of these studies focus on psychiatric disorders and potentially involve cognition or neurodegeneration.
Dominic D'Agostino discusses ongoing studies that are examining the effects of ketones on cognitive deficits in Alzheimer's disease. These studies are identifying patients, such as those with significant glucose hypometabolism, who respond favorably to ketone-based therapies.
He also mentions the Bazuki group funding million-dollar studies across severe psychiatric disorders at various universities, which shows the significant investment and int ...
Ketogenic Diets and Ketones for Neurodegenerative Disease Therapy
Ketone supplements, while beneficial in various ways, come with potential risks such as electrolyte imbalances. Researcher D'Agostino discusses the importance of managing these risks, as well as the mitigating effects of electrolyte blends in ketone supplements.
D'Agostino raises concerns about liver toxicity with 1,3-butanediol and its potential linkage to electrolyte imbalance from large doses over time. To mitigate electrolyte imbalances on a ketogenic diet, D'Agostino points out that consuming ketone electrolytes when starting the diet can help. His conversation indicates a push towards creating balanced formulations that include ketone salts — specifically sodium, potassium, calcium, and magnesium beta-hydroxybutyrate — to replenish electrolytes. He discusses creating a quad salt blend that provides both ketones and needed electrolytes. D'Agostino notes that the ketone salts, due to their ionic bond, act as a natural buffer when consumed in large doses, helping to prevent possible acidic conditions. He highlights that their current formulation does not lead to an excessively high electrolyte load given their absence of chloride, which often concerns additional electrolyte consumption.
D'Agostino mentions products such as Audacious Nutrition's Keto Start, which provides about one gram of electrolytes, including sodium, calcium, magnesium, and potassium. These products offer a viable solution for those initiating the ketogenic diet, aiming to prevent dehydration from the diet's natriuretic and diuretic effects. Furthermore, he addresses concerns over sodium overload from ketone salts and clarifies that the negative effects, including hypertension, are ...
Electrolyte Management and Formulations of Ketone Supplements
Dominic D'Agostino and Peter Attia discuss the promising applications of hyperbaric oxygen therapy (HBOT) in treating a range of conditions from traumatic brain injury to cancer, exploring its efficacy and the challenges associated with its use.
D'Agostino tr
aces the history of hyperbaric oxygen therapy, from seminal studies over a century ago to its potential as part of a comprehensive cancer treatment plan. The therapy's promise for augmenting standard care, particularly with respect to neurological and cancer conditions, is an ongoing area of interest. D'Agostino points to the research into HBOT's impact on glioblastoma cells. He also mentions funding for research into oxygen toxicity seizures related to diving, which has relevance to hyperbaric therapy's impact on the brain.
Recent developments extend the promise of hyperbaric oxygen therapy even further. Data soon to be released from different study groups suggests that HBOT can improve cognitive function in patients who have suffered a traumatic brain injury years earlier. The Aviv Clinic has seen significant improvements in patients after HBOT, lot only in cognitive function but also in cardiometabolic biomarkers. The Department of Defense has funded a $30 million trial investigating the neuroregenerative potential of HBOT, with results expected within the next year. D'Agostino notes that past studies without sham controls have anecdotal indications of benefits from hyperbaric oxygen therapy for long-ago brain injuries.
To address traumatic brain injury more specifically, D'Agostino recommends a standard protocol involving two atmospheres of oxygen for 60 to 90 minutes, five days a week, for a minimum of 40 treatment sessions. For a more mild protocol potentially suitable for mild concussions, a softer hyperbaric oxygen protocol of about 1.3 atmospheres three times per week over two weeks is suggested, using soft chambers available in some gyms.
D'Agostino also explores the combination of supplemental and dietary ketosis with HBOT, conducting clinical trials to see how they affect the latency to a seizure in a hyperbaric environment. These trials simulate diving conditions and are aimed at understanding how various therapies ca ...
Hyperbaric Oxygen Therapy
Download the Shortform Chrome extension for your browser
